ISTITUTO ROMAGNOLO PER LO STUDIO DEI TUMORI DINO AMADORI - IRST SRL
- Country
- Italy
- Type
- Beneficiary
- Grants received
- 10
Funding record
- 10 grants on record
- €4,480,033.58 awarded in total
- 2018–2025 years covered
This total adds up only the grants our sources publish. It is not the total funding this organisation has received.
Programmes
2 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations funded alongside this one on two or more projects. Sharing a single project does not count. Some projects have as many as 195 participants, and appearing on the same list once is not a working relationship.
- TIMELEX
- CHARITE - UNIVERSITAETSMEDIZIN BERLIN
- ALMA MATER STUDIORUM UNIVERSITA DI BOLOGNA
- ARTEEVO TECHNOLOGIES LTD
- AZIENDA USL DELLA ROMAGNA
- Centre hospitalier universitaire de Liège
- FONDAZIONE G.I.M.EM.A. - FRANCO MANDELLI ONLUS
- FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA
Calls from this organisation
No published calls from this organisation.
Grants received
- smart Mirrors supporting healthier lives of Adolescents and Young Adults after cancer
- Remote SWEATSkin PATCH for Monitoring Breast Cancer Therapeutic Response
- Residual disease assessment in hematologic malignancies to improve patient-relevant outcomes across Europe (RESOLVE)
- Federate Learning and mUlti-party computation Techniques for prostatE cancer
- Master Framework and Pragmatic Clinical Trial for Relapse or Refractory Acute Myeloid Leukemia
- Implementing value-based oncology care at European cancer hospitals: An AI-based framework for assessing real-life effectiveness of novel cancer therapies in real-time
- TRUstworthy Multi-site Privacy Enhancing Technologies
- Strengthening the European Chain of sUpply for next generation medical RadionuclidEs
- A digital guardian angel enhancing cancer patient’s wellbeing and health status improvement following treatment.
- International Randomized Study Comparing personalized, Risk-Stratified to Standard Breast Cancer Screening In Women Aged 40-70
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
We collected this from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.